The products and information provided by Bermuda Peptides are not intended to diagnose, treat, cure, or prevent any disease or medical condition
Inflammopharmacology (2006) This review examines the stable gastric pentadecapeptide BPC 157 (noted as safe in clinical trials for inflammatory bowel disease) and its cytoprotective activity in the context of the full, distended stomach and the vascular response
Ipamorelin/CJC-1295: These focus on growth hormone release, while BPC-157 works through different pathways focused on direct tissue repair
The following dosing protocol for healing with TB-500 is not supported by any studies published thus far, but it can serve as a starting point for researchers, who are advised to begin with still lower doses and titrate upward approaching this protocol: Daily Dose: 2mg, administered subcutaneously Frequency: Daily subcutaneous injections Study Duration: 15 days Notes: Researchers need three vials of TB-500 10mg to complete this protocol
More capillaries mean better nutrient delivery and waste removal, supporting all aspects of tissue repair